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Introduction
The mouse mammary gland is an excellent model system
with which to study both the regulation of development
and the functional differentiation of an organ. Most of the
development occurs postnatally, when the gland under-
goes a highly regulated cascade of invasive growth,
branching, differentiation, secretion, apoptosis and remod-
elling during each pregnancy cycle [1,2]. Terminal differ-
entiation of the alveolar epithelium is completed at the end
of gestation with the onset of milk secretion (lactation).
APR = acute-phase response; C/EBP = CCAAT/enhancer-binding protein; H&E = haematoxylin and eosin; IHC = immunohistochemistry; IL =
interleukin; LIF = leukaemia inhibitory factor; LPS = lipopolysaccharide; OSM = oncostatin M; RT–PCR = reverse transcriptase polymerase chain
reaction; SOM = self-organising map; TNF = tumour necrosis factor; WAP = whey acidic protein.
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Abstract
Introduction: Involution of the mammary gland is a complex
process of controlled apoptosis and tissue remodelling. The
aim of the project was to identify genes that are specifically
involved in this process.
Methods: We used Affymetrix oligonucleotide microarrays to
perform a detailed transcript analysis on the mechanism of
controlled involution after withdrawal of the pups at day seven
of lactation. Some of the results were confirmed by semi-
quantitative reverse transcriptase polymerase chain reaction,
Western blotting or immunohistochemistry.
Results: We identified 145 genes that were specifically
upregulated during the first 4 days of involution; of these,
49 encoded immunoglobulin genes. A further 12 genes,
including those encoding the signal transducer and activator of
transcription 3 (STAT3), the lipopolysaccharide receptor
(CD14) and lipopolysaccharide-binding protein (LBP), were
involved in the acute-phase response, demonstrating that the
expression of acute-phase response genes can occur in the
mammary gland itself and not only in the liver. Expression of
LBP and CD14 was upregulated, at both the RNA and protein
level, immediately after pup withdrawal; CD14 was strongly
expressed in the luminal epithelial cells. Other genes identified
suggested neutrophil activation early in involution, followed by
macrophage activation late in the process. Immuno-
histochemistry and histological staining confirmed the
infiltration of the involuting mammary tissue with neutrophils,
plasma cells, macrophages and eosinophils.
Conclusion: Oligonucleotide microarrays are a useful tool for
identifying genes that are involved in the complex
developmental process of mammary gland involution. The
genes identified are consistent with an immune cascade, with
an early acute-phase response that occurs in the mammary
gland itself and resembles a wound healing process.
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After weaning, the entire alveolar epithelium involutes.
Involution is reversible within the first 48–72 hours but
becomes irreversible thereafter [3]. Apoptosis of the alve-
olar cells commences within hours of forced weaning,
when milk accumulates within the alveolar lumen and the
levels of lactogenic hormones decrease. In teat-sealing
experiments, Li and colleagues [4] demonstrated that local
signals are sufficient to induce apoptosis in alveolar cells
and that a continued presence of systemic lactogenic hor-
mones or glucocorticoid injections is unable to block alveo-
lar cell death. During the second, irreversible phase of
involution, which is regulated by systemic hormones, the
lobuloalveolar architecture is remodelled by proteinase
degradation of the basement membrane and the extracellu-
lar matrix. The dying cells are finally removed by phagocyto-
sis. Within 2 weeks the gland has returned to a
morphological state similar to that of an adult virgin mouse.
Several important genes involved in this involution process
have previously been described [5] that operate in spe-
cific signalling pathways of remodelling or apoptosis. Our
goal was to identify over a defined time course the poten-
tial interplay between the processes involved in enforced
involution, by studying mRNA expression profiles after
withdrawal of the pups at day 7 of lactation. In recent
years, oligonucleotide microarray analysis has proved to
be a very efficient technique, allowing several thousand
genes and expressed sequence tags to be examined in
one hybridisation. At the same time, the quality of the
arrays and the analysis software have improved dramati-
cally and the applications for this technique have become
more and more widespread (see supplement to Nature
Genetics 32, December 2002).
Master and colleagues [6] have shown that microarrays
are a valuable tool for identifying pathways and cellular
processes during the development of mouse mammary
gland, when they identified a role for the mouse mammary
gland in adaptive thermogenesis during early pup develop-
ment. We therefore used oligonucleotide microarrays from
Affymetrix to investigate the transcriptional expression of
about 6000 known genes and another 6000 expressed
sequence tags during the first 4 days of mouse mammary
gland involution. In this study we identified 145 genes that
were specifically upregulated during the first 4 days of
involution. These genes illustrated a distinct immune
response, resembling a wound healing process, including
a primary neutrophil activation and a secondary
macrophage activation, a local acute-phase response
(APR) and a late B lymphocyte response without any signs
of infection. Using F4/80 antibody for immunohistochem-
istry (IHC) in addition to eosin staining, we showed that
infiltration of the mouse mammary tissue by macrophages
paralleled the increase of the identified transcripts during
involution, and that it was preceded by an activation and
increase in the number of neutrophils.
The study further revealed an unexpected infiltration of
eosinophils into the mammary tissue during involution. We
also showed that the APR protein lipopolysaccharide
(LPS)-binding protein (LBP) is not specifically expressed
in the liver but in the involuting gland itself, and that CD14
is strongly expressed in the luminal epithelial cells during
involution. We discuss a model of how LBP and CD14
might be involved in the clearance of the gland and how
neutrophils and macrophages could be activated during
the first 4 days of involution.
Materials and methods
RNA isolation
All animal work was conducted in accordance with
accepted standards of humane animal care, was in com-
pliance with the Helsinki Declaration and was approved by
an ethical committee. We used the fourth (inguinal)
mammary gland from three individual Balb/C mice per
time point from one flank. As morphological controls we
used the corresponding gland from the other side to gen-
erate whole mounts. The mice were mated at 12 weeks of
age to make sure that the glands were fully developed.
The glands were harvested at the following developmental
stages: virgin, 10 and 12 weeks; pregnancy days 1, 2, 3,
8.5, 12.5, 14.5 and 17.5; lactation days 1, 3 and 7; and
involution days 1, 2, 3, 4 and 20. For involution samples,
the pups were force-weaned after 7 days of lactation. The
lymph node within the gland was removed, the gland was
snap-frozen in liquid nitrogen and kept at –80°C until
further extraction. The glands were homogenised in a dis-
membrator (B Braun Biotech, Melsungen, Germany) and
were immediately treated with Trizol reagent (Invitrogen,
Paisley, UK). Total RNA was extracted in accordance with
the manufacturer’s protocol and eluted in nuclease-free
water. Small RNA fragments were removed by further
purification with RNeasy-mini columns (Qiagen, Hilden,
Germany) in accordance with the manufacturer’s protocol.
The RNA was quantified by spectrophotometer and the
quality was tested on an Agilent (Palo Alto, CA, USA) bio-
analyser.
Oligonucleotide microarray hybridisation
Total RNA (10 µg) from each time point was used for the
production of biotinylated cRNA as described in the
Affymetrix (High Wycombe, UK) manual. The quality of the
labelled cRNA was confirmed by hybridisation to an
Affymetrix test chip (Test3-chip). All experiments were per-
formed in triplicate with RNA from three individual mice.
Labelled cRNA (15 µg) was hybridised to the MG-U74Av2
chip from Affymetrix for 16 hours at 45°C in a rotating
hybridisation oven. After washing and staining of the chip
in an Affymetrix-Fluidic station, the chip was scanned in an
Agilent scanner and the raw data were analysed by the
Microarray Suite 5.0 software. All results were scaled to a
target signal of 100. The scaling factors of the individual
experiments did not differ more than threefold between
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each other. Results from 12,488 probe sets were col-
lected (see Additional file 1).
Data analysis
Details of the algorithms of the software are available at
http://www.Affymetrix.com. The data were included in a
database, constructed with Affymetrix MicroDB® software,
and analysed with the Affymetrix Data Mining Tool®
(DMT). For SOM (self-organising map) cluster analysis,
the expression profiles were prefiltered for a relative differ-
ence of more than 1.8-fold and an absolute difference
greater than 33 between the lowest and highest expres-
sion signals. The filter for the lowest signal was set to 20
and that for the highest signal to 20,000. Initialisation was
performed with random vectors, and a Gaussian neigh-
bourhood was selected.
In a first selection, the results of the probe sets showing at
least three signals with P≤0.04 or below were combined to
‘virgin’ (v10, v12), ‘early pregnancy’ (P1, P2, P3), ‘mid–late
pregnancy’ (P8.5, P12.5, P14.5, P17.5), ‘lactation’ (Lac1,
Lac2 Lac3), ‘early involution’ (Inv1, Inv2), ‘mid-involution’
(Inv3, Inv4) and ‘late involution’ (Inv20). Ten separate SOM
clustering analyses were performed (3×4) and only those
probe sets that were always in an early- or mid-involution
specific cluster were considered for further analyses (488
probe sets). For downregulated genes, only those probe
sets that were always in a cluster showing only downregula-
tion at involution were considered for further analysis (144
probe sets). Probe sets showing upregulation were then
used for another round of 10SOM clustering analyses
(4×5), but this time as individual time points. Those clus-
ters, which showed their highest expression either at Inv1,
Inv2, Inv3 or Inv4 and showed no upregulation at earlier time
points, were combined (379 probe sets).
For direct comparison of two time points, each of the
three experiments from one time point (Inv1, Inv2, Inv3 or
Inv4) was compared with each of the three experiments
from lactation day 7 used as baseline, to produce a total of
nine comparisons. Only probe sets that produced at least
eight out of nine change values of P ≤ 0.0024 (or
P ≥ 0.9976 for decrease) and for which all three signals of
the particular involution time point had a detection
P ≤ 0.04 were considered as being increased.
The degree of change between two time points is
described as the log ratio (2x) and reflects the average of
the nine comparisons. Only probe sets showing a log ratio
of at least 0.84 (1.8-fold) were selected (1044 probe sets
increased, 461 probe sets decreased). A combination of
the direct comparison result and the SOM clustering
resulted in 220 probe sets (21% of increased probe sets;
58% of probe sets identified through SOM clustering) for
upregulated genes and 44 probe sets (9.5% of decreased
probe sets; 30.5% of probe sets identified through SOM
clustering) for downregulated genes. Each of these was
again checked individually for involution-specific upregula-
tion or downregulation. The final selections of 152 probe
sets (14.5% of increased probe sets; 40% of probe sets
identified through SOM clustering) showing upregulation
and 16 probe sets (3.5% of decreased probe sets; 11.1%
of probe sets identified through SOM clustering) showing
downregulation reflected those which fitted this criterion
best (see Additional file 2). The 152 probe sets were
divided into immunoglobulin-encoding genes (49 genes)
and other genes and were further clustered by a Pearson
correlation clustering method, by using GeneSpring®
(Silicon Genetics, Redwood City, CA, USA).
Protein extracts and Western blotting
Protein extracts were made from 2–3 mm strips of the
fourth inguinal mammary gland between lymph node and
body and extracted in lysis buffer (50 mM Tris-HCl,
150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 50 mM
NaF plus protease inhibitor mix). The glands were
homogenised with a plastic homogeniser in a 1.5 ml tube,
incubated for 10 min at 4°C and centrifuged for 10 min at
20,000g at 4°C. The protein extracts (supernatant, 25 µg)
were separated on a 4–12% NuPage gel (Invitrogen) in
MES buffer under denaturing and reducing conditions.
The protein was transferred onto nitrocellulose membrane
(Schleicher and Schuell, Dassel, Germany) and the pro-
teins were detected by enhanced chemiluminescence
with Amersham ECL®.
The antibodies used were anti-LBP (N-17; dilution 1 : 500;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
(mouse CD14) (M-20; dilution 1 : 500; Santa Cruz
Biotechnology), and anti-(mouse β-actin) (ab205; dilution
1 : 8000; Abcam, Cambridge, UK).
Immunohistochemistry
The antibodies were used at the following dilutions:
1 : 500 biotinylated rat anti-(mouse B220) (RA3-6B2; BD
Biosciences-Pharmingen, San Diego, CA, USA), 1 : 40
goat anti-(mouse CD14) (M-20; Santa Cruz) and 1 : 50
rat anti-(mouse F4/80) (gift from JW Pollard). Paraffin-
embedded tissue sections were stained by using the
three-step streptavidin–biotin system incorporating
antigen retrieval by digestion for 10 min with 0.02%
trypsin. Endogenous biotin was blocked with an
avidin–biotin blocking system (Vector Labs, Burlingame,
CA, USA) and Fcγ receptors were pre-blocked with 10%
normal rabbit serum. Binding of streptavidin–biotin-
conjugated horseradish peroxidase was visualised by
using 3,3′-diaminobenzidine tetrahydrochloride. Sections
were counterstained with haematoxylin and eosin (H&E).
A fluorescein isothiocyanate-labelled neutrophil-specific
antibody (7/4; Caltag, Burlingame, CA, USA) was used for
immunofluorescent staining of frozen mammary tissue at
1 : 50 dilution.
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Staining with methyl green and pyronin
Paraffin sections were dewaxed and rehydrated, then
rinsed in pH 4.8 buffer (0.08 M acetic acid, 0.12 M sodium
acetate) and stained for 25 min in methyl green/pyronin
solution (9 ml of 2% aqueous methyl green CI 42590, 4 ml
of 2% aqueous pyronin Y, 23 ml of acetate buffer, pH 4.8,
and 14 ml of glycerol). Sections were again rinsed in
pH 4.8 buffer, followed by acetone/xylene (1 : 1). Finally
they were dehydrated, cleared and mounted.
Reverse transcriptase polymerase chain reaction
(RT–PCR)
Total RNA (10 µg) was treated with DNase (DNA-free™;
Invitrogen) in accordance with the manufacturer’s protocol
and resuspended in 100 µl of nuclease-free water. A 10 µl
portion of this solution was used to produce cDNA, using
SuperscriptII (Invitrogen) in accordance with the manufac-
turer’s protocol. This cDNA (1 µl) was used in each PCR
reaction with Hot-Star Taq polymerase (Qiagen). An
Eppendorf Mastercycler gradient was used for the chain
reaction, with 25–35 PCR cycles (30 s at 90°C, 30 s at
55–59°C, 30 s at 72°C). The following oligonucleotides
were used: GRO1, 5′-ACCGAAGTCATAGCCACACTC-
3′ and 5′-TTGACACTTAGTGGTCTCCCA-3′; LRG, 5′-
CAGCATCAAGGAAGCCTCCA-3′ and 5′-TTGGCCGAG-
GTGCTGAAC-3′; BMAC, 5′-CGAGGAGAAGATGGT-
TATCGTC-3′ and 5′-AGCATCAGCCTCCTTTGTGA-3′;
CD68, 5′-CAGCACAGTGGACATTCATG-3′ and 5′-GG-
TAACTGTTGAGTCAGTGGC-3′; β-actin, 5′-T(C/T)GTG-
ATGGACTCCGG(A/T)GAC-3′ and 5′-C(G/A)CCAGAC-
AGCACTGTGTTG-3′.
Results
To identify genes that were solely upregulated or downregu-
lated during involution of the mouse mammary gland, we per-
formed an oligonucleotide microarray analysis on total RNA
from all developmental stages of an adult virgin mammary
gland as outlined in the Materials and methods section.
We first tested for random variation between experiments
by comparing RNA expression signals of two individual
glands from the same mouse during mid-pregnancy
(day 11.5) with Affymetrix Microarray Suite 5.0 (data not
shown). The two arrays showed fewer than 1% changes
that were more than twofold (log ratio 1), which was in the
expected range of the Affymetrix arrays. Because RNA
samples were taken in triplicate for each time point and
each sample of lactation day 7 was cross-compared
against each of the samples of the involution time points
to identify upregulated or downregulated genes (nine
comparisons per involution time point), random variation
was reduced even further.
As controls, known gene expression profiles, including
those for the milk protein genes casein α, β, γ, δ, κ and buty-
rophilin, were tested for correct expression. They all
showed the expected upregulation during mid-pregnancy
and downregulation at the onset of involution, and, for
casein δ, upregulation at parturition (Fig.1a). Further control
genes with lower expression levels included those encoding
the transcription factors msh-like 2 (MSX2), LIM domain
only 4 (LMO4) and Bcl2-associated X-protein (BAX), which
showed the expected upregulation during early and mid-
pregnancy, and early involution respectively (Fig.1b–d).
Genes specific for involution
Having demonstrated that our controls showed the
expected expression profiles, we went on to identify those
genes that were specifically upregulated or downregu-
lated during involution, using the criteria and procedures
outlined in the Materials and methods section. We identi-
fied 152 probe sets, representing 145 genes (7 probe
sets were redundant), that were specifically upregulated
at least 1.8-fold (log ratio 0.84) after pup withdrawal
(Tables 1 and 2), but only 16 probe sets that were specifi-
cally downregulated (Table 3). Of the 152 probe sets
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Figure 1
RNA expression profiles of selected control genes. The graphs show
the scaled average signals (y-axis) for the milk protein genes casein α,
β, γ, δ, κ and butyrophilin (a), as well as the transcription factor genes
MSX2 (b) and LMO4 (c), and the pro-apoptotic gene BAX (d) at the
different stages of adult mouse mammary gland development (x-axis).
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Table 1
List of involution-specific genes clustered with the use of Pearson correlation clustering
DMT Log DMT Log
probe set ratio Gene description probe set ratio Gene description
Cluster 1
100034_at 3.42 Maspin
102712_at 3.27 Serum amyloid A3
98041_at 8.01 Ribonuclease 1, pancreatic
96056_at 1.42 RhoC
160686_at 2.07 Hypothetical transcription factor
101996_at 1.53 Protein tyrosine phosphatase, non-receptor 
type 2
95462_at 2.11 HFB2 homologue
99633_at 1.65 Neurochondrin-1
101892_f_at 0.86 Fused toes
104340_at 1.4 Methyl-CpG binding protein, MBD1
99582_at 1.27 Tumour-associated calcium signal transducer 1
103059_at 1.44 MAT8, FXYD domain-containing ion-transport
regulator 3
101583_at 0.89 B-cell translocation gene 2, anti-proliferative
100893_at 1.6 Serine palmitoyltransferase, long chain base
subunit 2
96657_at 1.81 Spermidine/spermine N1-acetyl transferase
93017_at 2.16 Syntenin
104725_at 2 Small ras-like GTPase Tc10
93220_at 2.33 Procollagen, type IV, α 5
101995_at 1.59 Sequestosome 1
160713_at 2.71 Arsenite inducible RNA-associated protein
(Airap)
95674_r_at 2.71 Brain-abundant membrane-attached signal
protein 1
160894_at 2.48 CCAAT/enhancer binding protein (C/EBP), δ
95673_s_at 6.11 Brain-abundant membrane-attached signal
protein 1
104701_at 2.42 Basic helix–loop–helix protein B2/DEC1
Cluster 2
95746_at 1.34 ATPase, H+ transporting, lysosomal (vacuolar
proton pump), α 70 kDa, isoform 1
97492_at 1.41 Hypothetical protein with thioredoxin domain
94850_at 1.17 Acyl-coenzyme A thioesterase 3, mitochondrial
95622_at 1 Host cell factor homologue
101410_at 2.96 Claudin 4/mCPE receptor
160106_at 1.73 Capping protein (actin filament), gelsolin-like
103305_at 3.52 Integrin β4
98151_s_at 1.06 Catenin Src
93347_at 0.88 RAB24, member of Ras oncogene family
Continued overleaf
Cluster 3
102761_at 1.47 GrpE-like 2, mitochondrial
162011_f_at 1.15 Ras homologue gene family, member U
96747_at 1.16 Ras homologue gene family, member U
103065_at 1.66 Solute carrier family 20, member 1
93435_at 8.41 Cytochrome P450, 24
95348_at 2.27 GRO1 chemokine (C-X-C motif) ligand 1, 
GRO1/CXCL1
95745_g_at 1.33 ATPase, H+ transporting, lysosomal (vacuolar
proton pump), alpha 70kDa, isoform 1
94734_at 4.14 α1-acid glycoprotein 2, orosomucoid 2
92312_at 1.33 Phosphatidylinositol 3-kinase p170
98910_at 0.84 Homology to ETS-domain protein ELK-1 from
rat
161139_f_at 1.8 DDEF1/development and differentiation
enhancing 1
Cluster 4
100136_at 1.15 Lysosomal membrane glycoprotein 2
101055_at 1.11 Protective protein for β-galactosidase
103812_at 3.31 Chloride channel calcium activated 1
101389_at 1.93 scavenger receptor class B, member 2
93728_at 2.73 Transforming growth factor β1 induced
transcript 4, TSC-22
101587_at 4.37 Microsomal epoxide hydrolase (Eph1), allele b
96119_s_at 3.32 Angiopoietin-like 4
97420_at 4.04 Leucine-rich α2-glycoprotein
102114_f_at 3.7 Angiopoietin-like 4/fasting-induced adipose
factor FIAF
Cluster 5
100513_at 2.39 DDEF1/development and differentiation
enhancing
93281_at 0.89 Taipoxin-associated calcium-binding protein
49 mRNA, reticulocalbin2
96738_at 1.61 Metalloprotease/disintegrin/cysteine-rich
protein precursor (MDC9)
100565_at 1.95 Glucosamine-6-phosphate deaminase
103503_at 2.06 Phospholipase Cγ2
(phosphatidylinositol-specific)
160127_at 1.01 Cyclin G1
97948_at 3.39 Retinoblastoma 1
Cluster 6
162479_f_at 0.89 Ferritin light chain 1
97529_at 3.12 Annexin 8
identified, 49 targeted immunoglobulins (Table 2). The
expression profiles of the other 103 probe sets (Table 1)
were clustered further with the Pearson correlation clus-
tering function in GeneSpring® to identify genes that were
expressed either early or late after pup removal (Fig. 2a).
The resulting gene tree was then grouped into 10 clusters
of similarly expressed genes.
Clusters 1, 2, 3 and 5 contained 46 genes that were all
characterised by their strongest expression on the first day
after forced weaning. Whereas cluster 1 showed a con-
stant baseline expression over all the other developmental
stages, genes in cluster 2 were additionally downregu-
lated during lactation, and genes in cluster 5 decreased
over the time course towards lactation day 7. Cluster 3
was of specific interest because it contained genes that
were upregulated only on the very first day after weaning
and were strongly downregulated on the second day. The
genes in these four clusters were therefore likely to be
involved in the immediate early events during the switch
from lactation to involution; six of them encode transcrip-
tional regulatory proteins. Genes in cluster 4 were also
upregulated on the first day, but their expression peaked
on day 2 of involution and declined thereafter. They are
therefore likely to be involved in secondary events during
the reversible stage of involution.
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Table 1 continued
List of involution-specific genes clustered with the use of Pearson correlation clustering
DMT Log DMT Log
probe set ratio Gene description probe set ratio Gene description
Cluster 7
102255_at 3.41 Oncostatin M receptor
162206_f_at 3.85 Suppressor of cytokine signalling 3
104155_f_at 1.79 ATF3 (LRG-21)
93294_at 4.31 Fibroblast inducible secreted protein,
connective tissue growth factor
102362_i_at 3.57 JunB
93536_at 1.61 Bcl2-associated X protein
103448_at 1.31 S100 calcium binding protein A8
(calgranulin A)
95680_at 1.22 Protein phosphatase 1, regulatory (inhibitor)
subunit 2
96953_at 1.49 Small inducible cytokine subfamily B
(Cys-X-Cys), member 14 /BMAC
99952_at 7.05 Chitinase 3-like 1
95681_f_at 2.09 Protein phosphatase 1, regulatory (inhibitor)
subunit 2
Cluster 8
100313_at 1.54 Integrin α8
101306_f_at 3.34 Serum amyloid A pseudogene
100333_at 2.34 Serum amyloid A2 (SAA-2)
96123_at 1.69 LPS-binding protein
96766_s_at 2.2 Receptor tyrosine kinase, Tyro3
96940_at 0.99 TEA-domain family member 2
100491_at 0.84 Solute carrier family 16 (monocarbox. acid
transporters), member 2
96592_at 2.39 Phosphatidylinositol 3-kinase, reg. subunit,
polypeptide 1 (p85α)
The genes are listed in their order of appearance in the gene tree after Pearson correlation clustering. The DMT probe set number refers to the
number of the probe on the Affymetrix MG-U74Av2 chip. The log ratio describes the average change of signal intensity between lactation day 7
and the day of highest expression during involution, on a log2 scale. The gene description refers to the description of the probe set on the NetAffx
website.
Cluster 8 (continued)
99133_at 1.65 Solute carrier family 3 (activators of dibasic and
neutral amino acid transport), member 2
102049_at 4.25 Pyruvate dehydrogenase kinase, isoenzyme 4
94881_at 3.49 Cyclin-dependent kinase inhibitor 1A (p21)
161650_at 1.94 Secretory leukoprotease inhibitor
92858_at 4.89 Secretory leukoprotease inhibitor
96614_at 1.67 Hypothetical protein
101963_at 1.61 Cathepsin L
92851_at 2.06 Caeruloplasmin
93753_at 1.58 LPS-induced TN factor
98088_at 2.6 CD14 antigen
101287_s_at 4.71 Cytochrome P450, 2d11
94384_at 1.28 Immediate early response 3
99099_at 0.93 Acute-phase response factor APRF/STAT3
102751_at 1.9 Transforming growth factor, β3
102313_at 1.15 GTP cyclohydrolase 1
Cluster 9
96679_at 1.25 DnaJ (Hsp40) homologue, subfamily B,
member 9
Cluster 10
103016_s_at 2.77 CD68 antigen
95706_at 4.15 Galectin 3
98543_at 2.69 Cathepsin S
99071_at 1.42 Macrophage-expressed gene 1, Mpeg1/MPS1
104023_at 1.2 Immunoglobulin superfamily, member 7
93318_at 2.59 Adhesion molecule ninjurin
Cluster 6 represented only two genes. Both showed a
strong upregulation on the first day and remained highly
expressed even 20 days after weaning, suggesting that
they might be important over the whole period of involu-
tion. Cluster 7, which included the pro-apoptotic factor
gene BAX, contained genes whose transcript level
increased on the first day but increased further towards
day 3 of involution. Genes in cluster 8 remained highly
expressed between the first and third day of involution,
after which they returned to baseline levels. This cluster
included the transcription factor gene STAT3/APRF or
acute-phase response factor. Cluster 9 contained only a
single gene, DnaJ [Hsp40] homologue, subfamily B,
member 9, coding for a mitochondrial stress protein. This
gene has a unique expression profile in that it was upregu-
lated on the second day after weaning and declined
strongly after day 3. The genes in cluster 10 were
expressed strongest late in involution (day 4) and there-
fore seem to represent genes that are needed only for the
second stage of involution.
Only 16 genes were specifically downregulated during
involution. Their transcript levels decreased on the first
day after weaning (Fig. 2b) and 11 of them encoded meta-
bolic or respiratory proteins. No anti-apoptotic or cell sur-
vival genes were specifically downregulated during this
involution stage.
A distinct lymphocytic response during the second
stage of involution
The 49 immunoglobulin genes identified showed a very
similar expression pattern (Fig. 3a). RNA levels increased
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Table 2
List of genes downregulated during involution
DMT Log
probe set ratio Gene description
101580_at −1.1 Cytochrome c oxidase subunit VIIb
92587_at −1.41 Ferredoxin 1
160091_at −1.14 Phosphoglycerate mutase 1
160385_at −1.24 RIKEN cDNA 5730591C18 gene
(hypothetical mitochondrial)
160184_at −1.26 RIKEN cDNA 1200007D18 gene
162077_f_at −2.04 Stearoyl-coenzyme A desaturase 2
93332_at −1.36 CD36 antigen
95611_at −1.82 Lipoprotein lipase
94966_at −1.11 Glucose-6-phosphate dehydrogenase X-linked
95053_s_at −0.91 Succinate dehydrogenase complex, subunit B,
iron sulphur (Ip) putative orthologue
99618_at −1.14 Homologous to ubiquinol–cytochrome c
reductase complex 6.4 kDa protein
(complex III subunit XI)
93308_s_at −2.03 Pyruvate carboxylase
98575_at −2.24 Fatty acid synthase
94427_at −0.91 Coatomer protein complex, subunit γ1
96850_at −0.95 Eukaryotic translation initiation factor 4 γ,
3, putative orthologue
99009_at −0.91 Nicotinamide nucleotide transhydrogenase
For notes, see footnote to Table 1.
Figure 2
Pearson correlation clustering of involution specific genes. (a) One
hundred and three upregulated probe sets identified through SOM
clustering were clustered with the Pearson correlation clustering
program of GeneSpring (Silicon Genetics). The colours (see colour
bar) represent a relative measure for the expression, with 1
representing the median, the red colour upregulated and blue
downregulated gene expression. The resulting gene tree was grouped
into 10 clusters of similarly expressed genes (shown bracketed at the
right) and their average expression patterns are shown on the right as
graphs (red lines) with standard deviations (blue lines) (DMT®;
Affymetrix). Note that the y-axes represent only arbitrary expression
levels and are not scaled identically between graphs. (b) Sixteen
downregulated genes were clustered by using the software mentioned
above and their average expression (red line) and standard deviations
(blue lines) are shown in the graph on the right (DMT®; Affymetrix).
Abbreviations: vir, virgin; preg, pregnancy; lac, lactation; inv, involution.
Breast Cancer Research    Vol 6 No 2 Stein et al.
R82
Table 3
List of immunoglobulin genes upregulated at involution
DMT Log
probe set ratio Gene description
100299_f_at 1.34 Igκ chain variable 8 (V8)
101331_f_at 1.86 Igκ chain variable 8 (V8)
102372_at 1.69 Immunoglobulin joining chain
161486_f_at 1.12 Immunoglobulin heavy chain (J558 family)
96964_at 1.1 Ig light chain V-region CC83 rearranged gene, exons 1 and 2
93638_s_at 4.28 Immunoglobulin lambda chain, variable 1
100322_at 1.37 Immunoglobulin heavy chain 4 (serum IgG1)
100362_f_at 1.97 Germline immunoglobulin V(H)II gene H8
100376_f_at 2.11 Clone BHS2.19 immunoglobulin heavy chain variable region precursor
97563_f_at 1.71 Ig heavy chain gene, CDR3 region
101320_f_at 1.14 Ig B cell antigen receptor gene
101319_f_at 1.36 Ig B  cell antigen receptor gene
98765_f_at 1.57 Immunoglobulin heavy chain (J558 family)
100360_f_at 1.7 Immunoglobulin heavy chain 4 (serum IgG1)
101718_f_at 1.65 Igκ chain variable 8 (V8)
97567_f_at 1.64 Igκ chain variable 8 (V8)
101640_f_at 1.75 Igκ chain variable 8 (V8)
96972_f_at 1.61 Igκ chain variable 8 (V8)
97566_f_at 1.66 Igκ chain variable 8 (V8)
101751_f_at 1.62 B-cell receptor
96971_f_at 1.91 Igκ light chain V-Jκ 5 joining region (cell line CH2)
102585_f_at 1.61 Igκ chain variable 8 (V8)
99369_f_at 1.6 Igκ light chain variable region precursor (Vk10c) gene
100721_f_at 1.46 Recombinant antineuraminidase single chain Ig VH and VL domains
101752_f_at 1.75 Immunoglobulin heavy chain 4 (serum IgG1)
102076_at 1.13 IgVκ aj4
100682_f_at 1.73 Igκ chain variable 8 (V8)
97575_f_at 1.64 Clone BHS3.26 immunoglobulin heavy chain variable region precursor
93927_f_at 2.53 Immunoglobulin heavy chain 4 (serum IgG1)
97577_f_at 1.55 Immunoglobulin heavy chain 6 (heavy chain of IgM)
97576_f_at 2.47 Immunoglobulin heavy chain 4 (serum IgG1)
97008_f_at 2.27 Clone CPS1.13 germline Ig variable region heavy chain precursor pseudogene
101747_f_at 1.79 (3C10) IgA V-D-J heavy chain
101871_f_at 2.28 Immunoglobulin heavy chain 4 (serum IgG1)
97574_f_at 2.34 Immunoglobulin heavy chain (J558 family)
101745_f_at 1.13 Immunoglobulin heavy chain 6 (heavy chain of IgM)
101720_f_at 1.75 Igκ chain variable 8 (V8)
97009_f_at 2.48 Immunoglobulin heavy chain variable region
102154_f_at 2.1 Igκ chain variable 8 (V8)
102155_f_at 1.09 Ig aberrantly rearranged κ-chain V10-J2 gene (Vκ-21 subfamily) from plasmacytoma 3386
102157_f_at 1.73 Igκ chain variable 8 (V8)
92470_f_at 1.54 Immunoglobulin heavy chain (J558 family)
94725_f_at 1.67 Variable light chain
93904_f_at 2.18 Clone N1.1.b immunoglobulin heavy chain VDJ region gene
96973_f_at 1.98 Ig V(H)II gene H18
101656_f_at 2.28 Igκ chain variable 5 (V5 family)
97564_f_at 2.37 Igκ light chain variable region
96975_at 1.7 Ig Vκ-PCG-4 gene
For notes, see footnote to Table 1.
slightly on day 7 of lactation, and this expression rate
remained the same on the first day of involution, but a
second, much stronger response was found between the
second day and fourth day after pup removal. By day 20 of
involution, expression of these genes had decreased, but
in 37 cases expression levels were still higher than in
12-week-old virgin mice. This finding pointed strongly
towards a B-cell response induced by enforced weaning.
To determine whether this upregulation was due to an
increased infiltration of B lymphocytes or plasma cells, or
merely reflected an increased transcriptional activity of
cells that were already present in the mammary tissue, we
performed IHC with antibodies against the B cell marker
B-220. The intra-mammary lymph node served as an inter-
nal positive control.
Plasma cells were identified in H&E-stained sections by
their characteristic shape, nuclear characteristics, clear
Golgi region and amphiphilic cytoplasm. They were con-
firmed by staining with methyl green and pyronin. To count
the number of cells per unit area, standard histological
methods were used: 20 high-power fields were randomly
selected with the section out of the plane of focus to
remove observer bias. Sections were then focused and
cells were counted. In all cases a section from each of
three individual mice was examined. The mean of the three
readings is recorded, together with the standard error
(Fig. 3a). There was a marked increase in plasma cells on
days 3 and 4. The intra-mammary lymph node had large
numbers of maturing plasma cells, which were migrating
from the hilum into the surrounding mammary tissue. All
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Figure 3
B-lymphocyte response during involution. (a) Pearson correlation clustering of immunoglobulin genes. The colours (see colour bar) represent a
relative measure for the expression level, with 1 representing the median. Forty-nine immunoglobulin genes that were upregulated during involution
were clustered by using the Pearson correlation clustering function from GeneSpring (Silicon Genetics); their average expression (red line) and
standard deviations (blue lines) are shown in the graph on the right (DMT®; Affymetrix). Note that the y-axis represents only an arbitrary level of
expression. Abbreviations: vir, virgin; preg, pregnancy; lac, lactation; inv, involution. (b) Cell count of plasma cells and B220+ B lymphocyes present
in the mammary tissue during involution. Tissue sections were stained either with methyl green and pyronin or with an antibody against CD45R,
and plasma cells and B lymphocytes were counted. Cell counts were taken from 20 high-power fields from each section in triplicate from three
individual mice.
measurements were therefore taken at a distance from the
region of the lymph node. In contrast with the plasma
cells, the number of B-220+ B lymphocytes showed no
obvious change (Fig. 3a).
Involution-specific genes describe a coordinated early
activation of neutrophils and late activation of
macrophages and eosinophils
On the basis of the finding of a plasma cell response during
involution, we looked for further indications of an immune
response. Although infiltration of immune cells, including
neutrophils and macrophages, into the mammary gland has
been reported for many animals during involution, this infil-
tration has not yet been shown for mice, rats or humans.
Further, it is so far largely unknown what attracts these
leukocytes to the mammary gland during involution. We
therefore investigated whether any of our identified genes
were involved in neutrophil or macrophage activation. We
found that the neutrophil-attracting chemokine encoded by
growth-related oncogene 1 (GRO1/CXCL1/KC) was
induced on the very first day of involution, followed by an
increased expression of the neutrophilic granulocyte marker
encoded by leucine-rich α2-glycoprotein (LRG) during the
first and second days (Fig.4a). In contrast, the expression of
the gene small inducible cytokine subfamily B (C-X-C)
member 14 (CXCL14/BMAC), encoding the B-cell and
macrophage-attracting chemokine (Fig.4b), and of the
macrophage-expressed chitinase 3-like1, was delayed
during involution and peaked only on the third day
(cluster 7). In addition, RNA levels of genes associated with
macrophage differentiation, including CD68 (Fig.4b),
cathepsin S, galectin 3 and macrophage-expressed gene
Mpeg1/MPS1 increased on days 3 and 4 of involution
(cluster 10).
To verify these results we performed semi-quantitative
RT–PCR for GRO1, LRG, CXCL14/BMAC and CD68,
which confirmed our microarray data (Fig. 4c). The expres-
sion profiles of our identified genes therefore described a
scenario in which forced weaning induces GRO1 expres-
sion and an early influx of neutrophils, followed by the
expression of CXCL14/BMAC and the activation of
macrophages. The gene encoding another major chemo-
kine for the recruitment and regulation of macrophages,
colony-stimulating factor 1 (CSF1), together with that of
its receptor, CSF1R, also showed increased expression
during involution, peaking on day 4 of involution (data not
shown). However, their expression profiles were not spe-
cific for the involution process and showed additional
upregulation in virgin mice and during early pregnancy.
To examine whether the increase in RNA levels was also
reflected in the number of neutrophils and macrophages
present in the mammary tissue, we stained three mammary
gland sections from three individual mice by IHC for the
macrophage marker F4/80 and counterstained with H&E.
Neutrophils were identified through their polymorphonu-
clear morphology, clear cytoplasm and only weak staining
with eosin (Fig. 4d). Their presence in the mammary gland
was confirmed with a fluorescein isothiocyanate-labelled
neutrophil-specific antibody on frozen mammary tissue
(data not shown). Neutrophils and macrophages were
counted from 20 and 50 high-power fields, respectively,
for each tissue section. Whereas the number of neu-
trophils increased on the first day, decreased slightly on
the second day and increased again on days 3 and 4, the
number of macrophages only increased markedly on the
fourth day, as could be seen by staining with F4/80 anti-
body (Fig. 4e). However, macrophage numbers in the sur-
rounding connective tissue increased already on day 3 of
involution (data not shown). In addition, we found a strong
increase in the number of eosinophils in the mammary
tissue on day 4 of involution. This cell type was identified
by its strong staining by eosin and its polymorphonuclear
morphology, and could be distinguished from neutrophils
by its staining with the F4/80 antibody and its granular
cytoplasm (Fig. 4d).
The involuting mammary gland shows an early APR
The transcription factor STAT3/APRF is a key component
of the involution process but is also strongly involved in
the APR as part of the innate immune system. We there-
fore asked whether any known STAT3 target genes or
members of the APR pathway were specifically upregu-
lated during involution.
Of the identified 96 genes, 12 were either directly associ-
ated with the APR or have been shown to be inducible by
LPS (Table 4). These included the transcription factor
gene STAT3 itself, whose RNA level was upregulated
nearly twofold on the first day of involution and remained
at that level of expression until day 3, after which it
dropped back to pre-involution levels. Five of the genes
associated with the APR pathway showed a similar
expression profile and were therefore grouped together
with STAT3 in cluster 8, including the genes LPS-binding
protein (LBP) and the LPS receptor CD14. These two
genes increased approximately threefold and sixfold
respectively (log ratios 1.69 and 2.6). Other LPS-induced
APR genes included in cluster 8 were serum amyloid A2
and serum amyloid pseudogene, caeruloplasmin, the
gene encoding the anti-inflammatory whey acidic protein
(WAP)-domain protein secretory leukoprotease inhibitor
(SLPI), and the transcription factor gene LPS-induced
TNF-α factor (LITAF). The immediate early response 3
gene, found in cluster 8, has a LPS-induced human ortho-
logue, differentiation-dependent gene 2 (DIF2), and was
therefore included in this list. Further genes of the APR
pathway, namely CCAAT/enhancer-binding protein δ
(C/EBPδ) and serum amyloid A3, grouped together in
cluster 1, whereas α1-acid glycoprotein 2 (orosomucoid 2)
was upregulated only on the first day of involution. The
Breast Cancer Research    Vol 6 No 2 Stein et al.
R84
anti-bacterial gene single WAP-motif protein 2 (SWAM2)
also showed a strong increase in its expression on the
very first day of forced involution, but was not included in
our list because it was also expressed during mid-preg-
nancy to late pregnancy.
LBP and CD14 proteins are expressed early during
involution in the absence of infections
The upregulation of LBP was surprising because LBP
function had so far been limited to LPS binding and its site
of synthesis mainly to hepatocytes. We therefore wished
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Figure 4
Activation of neutrophils, eosinophils and macrophages during involution. (a) RNA expression for GRO1/IL-8/KC and LRG derived from microarray
analysis. (b) RNA expression for BMAC, gp39, cathepsin S, MPS1, galectin 3 and CD68 derived from microarray analysis. The x-axes of both
graphs describe the different developmental stages: virgin (V10, V12), pregnancy (P1, P2, P3, P8.5, P12.5, P14.5, P17.5), lactation (Lac1, Lac3,
Lac7) and involution (Inv1, Inv2, Inv3, Inv4, Inv20). The y-axes describe the averaged scaled signal of the triplicate samples for each time point. The
intensity data for LRG have been scaled down 10-fold for display. (c) Semi-quantitative RT–PCR for GRO1, LRG, BMAC and CD68 from a fourth
independently collected RNA sample. (d) Identification of macrophages, neutrophils and eosinophils. The figure shows the immunohistochemical
staining of a paraffin-embedded tissue section from a mouse mammary gland after 4 days of involution. Macrophages were identified by staining
with F4/80 antibody and by their nuclear and cellular shapes. Eosinophils were identified by cross-reaction with the F4/80 antibody,
polymorphonuclear structure and eosin staining. Neutrophils were identified through their polymorphonuclear structure, clear cytoplasm, slight
eosin staining and non-staining with the F4/80 antibody. (e) Cell counts of neutrophils, eosinophils and macrophages present in the mammary
tissue during involution. Tissue sections were stained with an antibody against F4/80 and counterstained with H&E; neutrophils and macrophages
were counted. Cell counts were taken from 20 (neutrophils and eosinophils) and 50 (macrophages) high-power fields, respectively, from each
section in triplicate from three individual mice.
to confirm LBP expression in the mammary gland by other
means. We extracted protein from mouse mammary
glands from all stages of development and performed a
Western blot analysis. This blot showed a strong increase
in the amount of LBP in the mammary gland on the first
day of involution, accompanied by a strong increase in the
expression of CD14 protein (Fig. 5a). To ensure that this
was not purely a consequence of a bacterial infection, we
examined formalin-fixed paraffin-embedded tissue sections
from lactation and early involution for the presence of
pathogens by Gram staining. Neither Gram-negative nor
Gram-positive bacteria could be detected in any of the
samples analysed (data not shown).
CD14 is expressed in the luminal epithelial cells of the
mouse mammary gland
CD14 is a known monocyte marker protein and is strongly
involved in the phagocytosis of apoptotic cells by
macrophages. Because luminal epithelial cells are involved
in the phagocytosis of neighbouring apoptotic mammary
epithelial cells during involution, we wished to know
whether CD14 was also expressed in the luminal epithe-
lium. We therefore performed IHC with a CD14-specific
antibody. This revealed a strong increase in CD14 expres-
sion in the luminal epithelial cells at day 1 of involution, but
not in the stroma (Fig. 5b). Unfortunately, LBP could not
be detected by IHC either in paraffin-embedded or frozen
mammary gland tissue, or in mouse liver sections with any
antibody tested (data not shown).
Discussion
Involution of the mammary gland comprises a very
complex and highly regulated cascade of programmed cell
death and remodelling. It is believed to occur in two
stages [3]: first, a reversible phase, lasting for about
2 days and characterised by an increased rate of apopto-
sis, and second, an irreversible remodelling phase that
starts on the third day after forced weaning. To determine
which genes are specifically expressed during the first
4 days of involution, we performed an oligonucleotide-
microarray analysis over the pregnancy cycle of an adult
mouse. We identified 145 genes that were specifically
upregulated after removal of the pups, and obtained a
comprehensive picture of the transcript changes that
occur specifically during the first 4 days after forced
weaning. Many of the genes identified have not previously
been linked to involution. Our data imply that forced
weaning in mice introduces an immune response in the
mammary gland similar to that seen in wound repair.
These data are in general agreement with the data pub-
lished in this issue by Clarkson and colleagues [7], who
used a different mouse system and a different analytical
approach.
The APR pathway is activated during involution
The APR represents the first defence mechanism against
disease and is part of the innate immune system, aimed at
minimising tissue damage while enhancing repair
processes [8]. After injury or infection, acute-phase
protein expression is usually stimulated in the liver by the
release of cytokines such as interleukin-1 (IL-1),
interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α)
from macrophages and monocytes at the sites of the
trauma [9–11]. We identified 12 genes that were upregu-
lated during the first 3 days of involution that either could
be directly linked to the APR pathway or can in general be
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Table 4
List of acute-phase response-inducible and lipopolysaccharide-inducible proteins
Gene name Genbank accession no. Function Cluster References
APRF/STAT3 U08378 Transcription factor 8 [15,16]
C/EBPδ X61800 Transcription factor 1 [21]
LPS-induced TNF-α factor, LITAF AI852632 Transcription factor 8 [61]
CD14 X13333 LPS receptor 8 [26]
LBP X99347 LPS-binding protein 8 [18]
Serum amyloid A2 M13521 Acute-phase response 8 [62]
Serum amyloid A3 X03505 Acute-phase response 1 [62]
Serum amyloid pseudogene M17790 Acute-phase response? 8 [62]
α1-acid glycoprotein 2 M12566 Acute-phase response 3 [63]
Caeruloplasmin U49430 Acute-phase response 8 [64]
Secretory leukoprotease inhibitor AF002719 Protease inhibitor 8 [36]
Immediate early response 3 (DIF2) X67644 Immediate early response 8 [65]
LPS, lipopolysaccharide.
activated by LPS, suggesting an important role for the
APR pathway in involution. The finding that treatment of a
mouse mammary gland with endotoxin leads not only to an
increased resistance to staphylococcal mastitis but also to
an accelerated involution of the gland itself [12] supports
our hypothesis and suggests that a LPS-inducible immune
response could be directly involved in the involution
process. Our data also show that acute-phase proteins can
be expressed in the mammary gland and do not act exclu-
sively in a systemic way, or only during bacterial infection.
One of the genes identified encoded the transcription
factor and key regulator of mammary gland involution
STAT3 [13,14], which is also known as acute-phase
response factor APRF [15,16]. Our data imply that a main
function of STAT3 during this developmental stage might
be the activation of this pathway. During an APR, STAT3
activates the genes α2-macroglobulin [17], LBP [18] and
C/EBPδ [19]. C/EBPδ is also involved in the activation of
LBP after IL-6 signalling in hepatocytes [18] and of the
genes α1-acid glycoprotein [20] and serum amyloid A
[21], and activates CD14 transcription in transient trans-
fection assays [22]. All these genes, with the exception of
α2-macroglobulin, which was undetectable in our study,
were upregulated on the first day after forced weaning.
However, their function during mammary gland involution
is not yet clear. LBP activity has previously only been
linked to the presentation of LPS to the LPS receptor
CD14 during infection, whereas CD14 itself has also
been linked to the phagocytosis of apoptotic cells [23].
The latter is commonly found on monocytes and
macrophages [24,25] and on circulating polymorphonu-
clear neutrophil leukocytes in cattle [26], but can also be
expressed by MCF7 cells in culture [27].
It has previously been shown that during involution apo-
ptotic cells are phagocytosed not only by macrophages but
also directly by their neighbouring epithelial cells [28–30].
We have now shown that CD14 is also expressed in vivo
in the luminal epithelial cells during involution, suggesting
that it might also be involved in the phagocytosis of apop-
totic cells by surviving epithelial cells. Unfortunately, to our
knowledge there are no antibodies available against LBP
that could be successfully used for localisation studies.
Although CD14-dependent apoptotic cell clearance by
macrophages in cell culture does not seem to require LBP
[31], this has not been demonstrated in vivo and might not
be true for phagocytosis by mammary epithelial cells. Our
finding that the transcript and protein level of LBP
increased in parallel to CD14 at the onset of involution and
in the absence of any bacterial infection suggests that LBP
might also be involved in this important process. Since
LBP is a downstream target of STAT3, and CD14 can be
activated by C/EBPδ, one function of STAT3 as APR factor
might be to enhance phagocytosis through the activation of
C/EBPδ and hence LBP, to clear apoptotic cells from the
mammary gland.
In contrast with bacterial infections, in which CD14-
dependent phagocytosis through macrophages leads to
the secretion of TNF-α and to inflammation [32], this is
actively suppressed when macrophages phagocytose
apoptotic cells [23,33]. The mechanism behind this phe-
nomenon is not yet fully understood. At least three of our
identified APR genes, α1-acid glycoprotein 2, caeruloplas-
min and SLPI, were upregulated on the first day after
forced weaning and have been shown to modulate the
activity of the immune system negatively during the acute-
phase reaction, protecting cells from endotoxic shock
[34–36]. They are therefore potential candidates for the
active suppression of inflammation during involution.
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Figure 5
LBP and CD14 expression in the mouse mammary gland. (a) Western
blot for LBP and CD14. Protein extracts from mouse mammary glands
from the developmental stages virgin 12 weeks, pregnancy days 1, 2,
3, 8.5, 12.5 and 17.5, lactation days 1, 3 and 7, and involution days 1,
2, 3, 4 and 20 were separated on a denaturing gel; Western blotting
was performed with anti-LBP, anti-CD14 and anti-β-actin antibodies.
(b) Localisation of CD14 protein by immunohistochemistry. Paraffin-
embedded sections from 7 days lactating (i, ii) and 2 days involuting
(iii, iv) mouse mammary glands were stained with an anti-CD14-
specific antibody. Negative controls contained no primary antibody.
During an APR, STAT3 is rapidly activated by tyrosine
phosphorylation in response to IL-5, IL-6, epidermal
growth factor, leukaemia inhibitory factor (LIF),
oncostatin M (OSM), IL-11 and ciliary neurotrophic factor
[37]. However, it is still controversial how STAT3
becomes activated during mammary gland involution. Hutt
and DeWille [38] demonstrated that the IL-6 type cytokine
OSM inhibits the growth of HC11 mouse mammary
epithelial cells via a phospho-STAT3-dependent pathway
and C/EBPδ. In addition, treatment of non-malignant
human breast epithelial cells with OSM or LIF can inhibit
proliferation [39]. Recently, LIF has been shown to partici-
pate in mouse mammary gland involution and to induce
apoptosis in mammary epithelial cells [40]. In our study,
the RNA level of the OSM receptor (OSMR) increased
more than 10-fold specifically during the first 3 days of
involution, supporting the view that OSM has a role during
involution. Unfortunately, there was no probe for OSM on
the array. In contrast, Kritikou and colleagues [41] recently
found that the LIF receptor LIFR was upregulated
72 hours after forced weaning and that LIF−/− mice
showed no phosphorylation of STAT3, indicating that
STAT3 signalling during mammary gland involution was
LIF-specific. However, the status of OSM in LIF−/− mice
has not been shown, and because OSM and LIF are
linked very closely on chromosome 11 it might be possible
that OSM expression has also been directly or indirectly
affected in the LIF−/− mice.
Thus, our data suggest a major role for the APR during the
first days of mouse mammary gland involution, with possi-
ble roles in phagocytosis of apoptotic cells and the sup-
pression of inflammation, and that OSM might have a role
in the activation of the APR factor STAT3.
Gene expression profiles point to an early neutrophil
response during involution
Although the early presence of neutrophils and the late
presence of macrophages have been reported in the invo-
lution secretions of many species, including pigs, guinea
pigs, sheep and cows [42–45], the same has not been
reported for rats, humans or mice [30]. Our gene expres-
sion data strongly support a role for these cells during
mouse mammary gland involution because the neutrophil-
specific chemokine GRO1/CXCL1 was specifically upreg-
ulated fivefold on the first day of involution, and the
neutrophilic-granulocyte marker LRG [46] was upregu-
lated most strongly on day 2 after forced weaning
(Fig. 4a,c). This was confirmed by an elevated number of
neutrophils (Fig. 4e) that infiltrated the mammary tissue
after forced weaning, a response similar to that found in a
healing wound [47]. However, whereas the transcript of
LRG peaks on the second day after weaning, cell numbers
decreased again slightly before increasing again on
days 3 and 4. The elevated RNA level therefore reflects
not only the influx of neutrophils into the mammary gland
but also a transcriptional activation or RNA stabilisation of
LRG. It is of interest to note that during days 1 and 2 after
weaning, neutrophils were mainly localised in the blood
vessels, whereas they were found mainly in the mammary
tissue during days 3 and 4 (data not shown).
GRO1/CXCL1 is the murine functional orthologue of the
human interleukin 8 (IL-8) [48]. It is expressed in
macrophages but the level of expression is reduced after
phagocytosis of apoptotic cells [33]. On injury or during
an inflammatory response it is also expressed in various
epithelial cells [49–52] before many other chemokines
[47,53,54]. It has an important role in wound healing [47],
is maximally expressed 1 day after injury in a superficial
woundbed and is spatially and temporally associated with
neutrophil infiltration [47]. Because GRO1/CXCL1 can
also be expressed in mammary epithelial cells [55], and
LPS–CD14 complexes have been found to bind to Toll-
like receptors on endothelial and epithelial cells, causing
the release of IL-8 [56], it would be of interest to learn
whether CD14 binding to apoptotic cells during mammary
gland involution could induce GRO1/CXCL1 secretion
from the mouse mammary epithelium.
Genes for macrophage differentiation suggest a
secondary macrophage infiltration
Macrophages not only have an important role in the host
defence mechanism but also function in normal tissue
development and in postnatal mammary gland develop-
ment [57]. Mice that carry a null mutation in the gene for
the major growth factor for macrophages, CSF1, have a
depleted population of macrophages in the mammary
glands, leading to an impaired branching morphology [57].
Macrophages are also strongly involved in the clearance
of apoptotic cells from the involuting mammary gland [28]
and macrophage-specific genes have been found to be
upregulated 7 days after forced weaning [6], whereas an
increase in macrophage cell number has been reported
from day 3 onwards [3]. The latter finding could be con-
firmed by using an F4/80 antibody, with macrophage
numbers inside the mammary tissue clearly increasing on
day 4 of involution, whereas the number of macrophages
localised in the surrounding connective tissue already
increased on day 3 (data not shown).
Interestingly, there was a marked increase in the number
of eosinophils parallel to the increase of macrophages in
the involuting tissue. Eosinophils, together with
macrophages, are important for postnatal mammary
gland development [57], and mice that are negative for
eotaxin, a major eosinophilic chemo-attractant, show
reduced branching and development of terminal end
buds [57]. However, their specific function during
mammary gland development is still unknown. Our data
have now shown that eosinophils are present not only in
the postnatal mammary gland but also in increasing
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amounts in the involuting mammary gland, and that this
increase was paralleled by a slightly elevated amount of
eotaxin mRNA (data not shown). This points to an addi-
tional biological function of eosinophils in the mouse
mammary gland distinct from any allergic response or
defence against parasites.
Although we found a slight increase in the RNA levels of
both CSF1 and its receptor, CSFR1, which paralleled the
expression of the other macrophage specific genes, these
genes were also upregulated in virgin mice and during
early pregnancy and are therefore not specific to involu-
tion. Instead, we found that the macrophage-attracting
chemokine gene CXCL14/BMAC, the mouse orthologue
of human BRAK, was increasingly expressed 3–4 days
after involution was initiated, as were five genes associ-
ated with macrophage differentiation (Fig. 4b,c). In parallel,
we found an increase in the number of macrophages 3
days after forced weaning (Fig. 4e). CXCL14/BMAC is
expressed in several tissues including breast [58], and
BRAK is secreted by fibroblasts and various epithelia to
attract CD14+ monocytes to sites of inflammation [59],
where they differentiate into macrophages. CXCL14/
BMAC is therefore a candidate signal for monocyte migra-
tion into the mammary gland during involution. These
results again show that macrophages are not induced
immediately after forced weaning but as a secondary
response, after the activation of neutrophil-attracting and
APR genes on the first day of involution. Figure 6 shows a
hypothetical model of how phagocytosis might lead to a
primary neutrophil activation, followed by secondary
monocyte/macrophage activation.
Plasma cell numbers increase during involution
The largest group of genes upregulated during involution
belonged to the immunoglobulin family. This increase was
paralleled by an increased number of plasma cells in the
tissue (Fig. 3b), suggesting that the elevated immunoglob-
ulin RNA levels are due to an influx of plasma cells into the
mammary tissue, rather than only a transcriptional activa-
tion. This is in agreement with an increase in plasma cell
number late during the dry period of an uninfected bovine
mammary gland [60]. However, whereas in cattle the
expression of immunoglobulins increases further until very
late in involution [60], the same was not seen in mice.
Instead, RNA expression decreased again towards day 20
after forced weaning. Immunoglobulins in the involuting
mammary gland are believed to opsonise bacteria and to
act as antitoxins, when the possibility of infection is great-
est immediately after weaning. Whether the increase
could also reflect an immune response towards the vast
amount of cell death in the tissue is still open to specula-
tion. It has been shown that macrophages that phagocy-
tose apoptotic cells degrade them completely and are
incapable of antigen presentation to T-cells, and that there
is therefore no specific, antibody-mediated immune
response to self-antigens during mammary involution [30].
However, this is still controversial [29].
Conclusion
Our work has shown that microarray analysis can be used
to characterise a complex developmental system and the
processes that occur during the different stages, and to
identify genes that are involved in the early stages of
mouse mammary gland involution. Although the physiolog-
ical significance of many newly identified genes in the
involution process still has to be verified, our study has,
together with the accompanied publication in this issue by
Clarkson and colleagues [7], for the first time given a com-
prehensive picture of the transcriptional changes that
occur during this very important developmental process.
At the same time it has posed many new questions and
formed a base on which to build future work. In particular,
the main function of STAT3/APRF during involution still
remains to be resolved. Transcriptome analysis of a condi-
tional STAT3-null mouse after forced weaning should give
us valuable insight into the pathways induced by STAT3
during mammary gland involution. It would also be of sig-
nificant importance to learn whether mammary glands from
LBP or CD14 knockout mice showed any signs of
delayed phagocytosis or involution.
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Figure 6
Model for early neutrophil and late macrophage activation. Apoptotic
cells are recognised and phagocytosed by their neighbouring epithelial
cells or professional and semi-professional cells (curved black arrows).
This recognition and/or phagocytosis might involve LBP, CD14,
signalling down by means of the Toll-like receptor 4 (TLR4). Activation
of this receptor could lead to secretion of the neutrophil-attracting
chemokine GRO1/IL-8 (red arrow) and to the attraction of neutrophils
to the area of trauma (yellow arrow). This is followed by secretion of
the CD14+-monocyte-attracting chemokine BMAC (broken arrow),
which could lead to monocyte infiltration on days 3 and 4 of involution
(yellow arrow); monocytes would subsequently differentiate into
macrophages.
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